Keyphrases
Lung Adenocarcinoma
100%
Prognostic Value
100%
Predictive Value
100%
KRAS Oncogene
100%
Recurrence-free Survival
100%
Overall Survival
83%
Mutant Allele-specific Imbalance
66%
Chemotherapy-induced
33%
Multivariate Analysis
33%
Codon
33%
Univariate Analysis
33%
Codon 13
33%
Lung Cancer
16%
Novel Therapies
16%
Chemotherapy
16%
KRAS mutation
16%
Mutational Analysis
16%
Prognostic Implications
16%
American Cancer Society
16%
Ras2
16%
Therapeutic Implications
16%
Kirsten Rat Sarcoma Viral Oncogene Homolog
16%
Prognosis Value
16%
Substitution Type
16%
KRAS-mutant Lung Adenocarcinoma
16%
Medicine and Dentistry
Lung Adenocarcinoma
100%
Oncogene
100%
Recurrence Free Survival
100%
Overall Survival
83%
Allele
66%
Codon
66%
Malignant Neoplasm
33%
Multivariate Analysis
33%
Univariate Analysis
33%
Disease
16%
Biological Marker
16%
Prospective Study
16%
Sarcoma
16%
Lung Cancer
16%
Mutational Analysis
16%
Virus Oncogene
16%
Biochemistry, Genetics and Molecular Biology
Oncogene
100%
KRAS
100%
Recurrence Free Survival
54%
Overall Survival
45%
Allele
36%
Codon
36%
Multivariate Analysis
18%
Prospective Study
9%
Ras2
9%
Virus Oncogene
9%